L4 Advanced PD Flashcards
Late Stage PD is stages (Hoehn and Yahr Scale)…
4 and 5
Stage 4: Severe disability, still able to walk or stand unassisted
Stage 5: w/c bound or bedridden unless assisted
Carbidopa-levodopa Side effects
GI disturbances
orthostatic hypotension
psychiatric problems
Levodopa
most effective drug for treating PD
broken down into dopamine the brain can use after cross the BBB
Carbidopa
decarboxylase inhibitor that prevents that breakdown of levodopa to dopamine in PNS
Difficulties with levodopa therapies over time
- wearing off, decreased effectiveness of the therapies at the end of period between doses
- induced dyskinesias or excessive movement due to abnormal response to dopamine in system
- manage with extended or sustained release versions of levodopa
Wearing-off phenomenon for levodopa
- describes the recurrence of motor and non-motor s/s during levodopa-free interval
- affects nearly all pts within 10 years of starting meds
RF for developing wearing off phenomenon
- younger age at presentation of initial s/s
- female
- long-duration of tx w/levodopa
- higher doses of levodopa
- use of dopamine agonists
Exam timing in PTs with PD
- Time of day should be consistent to establish accurate baseline
- Time of day should be the same for exam of patient for baseline and all other follow up progress notes
- wearing off will be individual for each patient
Common off times
- 1st thing in the morning
- between doses of levodopa
- can be gradual or like a switch
Levodopa Induced Dyskinesia
- long-term use can lead to motor fluctuations and dyskinesias
- s/s are more likely to start on side of body first impacted
- starts usually after 6 years of treatment with levodopa for about 50% of patients
- more likely in pts with advanced PD s/s
RF for levodopa-induced dysfinesia
- developing s/s of PD at younger ages (40s)
- higher cumulative dose
- low body weight
- natives of north american geographic region
- female
- more severe UPDRS Part 2 score
DBS for PD
- ideal window is when pts are still responding to levodopa but not able to control motor s/s with medication alone
- treats motor s/s like stiffness, tremor, dyskinesias
- allows for lower dose of meds to treat PD
- good for 1-2 years, long term benefit is less clear, but can be up to 10 yrs
Who is a candidate for DBS?
- pts with uncontrollable tremor for whom meds have not been effective
- pts with s/s that respond well to meds but who, when drugs wear off, experience severe motor fluctuations and dyskinesias, despite medication adjustments
- pts whose movement symptoms might respond to higher or more frequent med doses, but are limited to do so because of side effects
Other S/S associated with advanced PD
- Dysphagia and aspiration pneumonia
- Depression
- Cognitive Decline
- Sleep dysfunction
- GI dysfunction
- Urinary Tract Dysfunction
Dysphagia and aspiration pneumonia
- any pt that develops weakness of chewing and swallow muscles due to any a disease will be at risk for dysphagia and aspiration pneumonia
- observing symptoms of aspiration pneumonia and dysphagia would be a reason to refer to a MD/SLP